245 related articles for article (PubMed ID: 33283280)
1. The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia.
Tao S; Kichula KM; Harrison GF; Farias TDJ; Palmer WH; Leaton LA; Hajar CGN; Zefarina Z; Edinur HA; Zhu F; Norman PJ
Immunology; 2021 Apr; 162(4):389-404. PubMed ID: 33283280
[TBL] [Abstract][Full Text] [Related]
2. Association of maternal KIR and fetal HLA-C genes with the risk of preeclampsia in the Chinese Han population.
Long W; Shi Z; Fan S; Liu L; Lu Y; Guo X; Rong C; Cui X; Ding H
Placenta; 2015 Apr; 36(4):433-7. PubMed ID: 24951171
[TBL] [Abstract][Full Text] [Related]
3. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2
Nemat-Gorgani N; Hilton HG; Henn BM; Lin M; Gignoux CR; Myrick JW; Werely CJ; Granka JM; Möller M; Hoal EG; Yawata M; Yawata N; Boelen L; Asquith B; Parham P; Norman PJ
J Immunol; 2018 Apr; 200(8):2640-2655. PubMed ID: 29549179
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
5. [The characteristics of frequency distribution of KIR2DL1 alleles polymorphism and recognition HLA-C ligand in the Chinese Han population].
Wang M; He J; Bao XJ; Qiu QC; Li Y; Xu C; Yuan XN; Li LJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1038-43. PubMed ID: 24369161
[TBL] [Abstract][Full Text] [Related]
6. High-Resolution Genetic and Phenotypic Analysis of KIR2DL1 Alleles and Their Association with Pre-Eclampsia.
Huhn O; Chazara O; Ivarsson MA; Retière C; Venkatesan TC; Norman PJ; Hilton HG; Jayaraman J; Traherne JA; Trowsdale J; Ito M; Kling C; Parham P; Ghadially H; Moffett A; Sharkey AM; Colucci F
J Immunol; 2018 Nov; 201(9):2593-2601. PubMed ID: 30249807
[TBL] [Abstract][Full Text] [Related]
7. Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Marin WM; Norberg SJ; Ashouri E; Jayaraman J; Wroblewski EE; Trowsdale J; Rajalingam R; Oksenberg JR; Chiaroni J; Guethlein LA; Traherne JA; Ronaghi M; Parham P
Am J Hum Genet; 2016 Aug; 99(2):375-91. PubMed ID: 27486779
[TBL] [Abstract][Full Text] [Related]
8. Variation of maternal KIR and fetal HLA-C genes in reproductive failure: too early for clinical intervention.
Moffett A; Chazara O; Colucci F; Johnson MH
Reprod Biomed Online; 2016 Dec; 33(6):763-769. PubMed ID: 27751789
[TBL] [Abstract][Full Text] [Related]
9. Loss and Gain of Natural Killer Cell Receptor Function in an African Hunter-Gatherer Population.
Hilton HG; Norman PJ; Nemat-Gorgani N; Goyos A; Hollenbach JA; Henn BM; Gignoux CR; Guethlein LA; Parham P
PLoS Genet; 2015 Aug; 11(8):e1005439. PubMed ID: 26292085
[TBL] [Abstract][Full Text] [Related]
10. Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.
Falco M; Meazza R; Alicata C; Canevali P; Muntasell A; Bottino C; Moretta L; Pende D; Lopez-Botet M
HLA; 2022 Aug; 100(2):107-118. PubMed ID: 35411634
[TBL] [Abstract][Full Text] [Related]
11. Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma.
Dutta A; Saikia N; Phookan J; Baruah MN; Baruah S
Immunogenetics; 2014 Aug; 66(7-8):439-48. PubMed ID: 24818561
[TBL] [Abstract][Full Text] [Related]
12. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
[TBL] [Abstract][Full Text] [Related]
13. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
[TBL] [Abstract][Full Text] [Related]
14. The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia.
Johnsen GM; Størvold GL; Drabbels JJM; Haasnoot GW; Eikmans M; Spruyt-Gerritse MJ; Alnæs-Katjavivi P; Scherjon SA; Redman CWG; Claas FHJ; Staff AC
J Reprod Immunol; 2018 Sep; 129():23-29. PubMed ID: 30055414
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinant-based typing of KIR alleles and KIR ligands.
Bari R; Leung M; Turner VE; Embrey C; Rooney B; Holladay M; Leung W
Clin Immunol; 2011 Mar; 138(3):274-81. PubMed ID: 21239231
[TBL] [Abstract][Full Text] [Related]
16. Characterization of KIR
Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
[TBL] [Abstract][Full Text] [Related]
17. Single Nucleotide Polymorphism in
Vargas LB; Dourado RM; Amorim LM; Ho B; Calonga-Solís V; Issler HC; Marin WM; Beltrame MH; Petzl-Erler ML; Hollenbach JA; Augusto DG
Front Immunol; 2020; 11():1881. PubMed ID: 32983108
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
19. Interaction of parental KIR and fetal HLA-C genotypes with the risk of preeclampsia.
Yu H; Pan N; Shen Y; Jin S; Zhai J; Qiao D; Shen Y; Miao F; Wang L; He Y; Ren M; Zhang J
Hypertens Pregnancy; 2014 Nov; 33(4):402-11. PubMed ID: 24911933
[TBL] [Abstract][Full Text] [Related]
20. Allelic Polymorphisms of Killer Immunoglobulin-Like Receptor Genes in Malay and Orang Asli Populations of Peninsular Malaysia.
NurWaliyuddin HZA; Norazmi MN; Zafarina Z
Hum Immunol; 2022 Jul; 83(7):564-573. PubMed ID: 35483989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]